Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1069120-19-9

Post Buying Request

1069120-19-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1069120-19-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1069120-19-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,9,1,2 and 0 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1069120-19:
(9*1)+(8*0)+(7*6)+(6*9)+(5*1)+(4*2)+(3*0)+(2*1)+(1*9)=129
129 % 10 = 9
So 1069120-19-9 is a valid CAS Registry Number.

1069120-19-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H62557)  cis-1-(Boc-amino)-4-(2-hydroxyethyl)cyclohexane, 97%   

  • 1069120-19-9

  • 250mg

  • 2083.0CNY

  • Detail
  • Alfa Aesar

  • (H62557)  cis-1-(Boc-amino)-4-(2-hydroxyethyl)cyclohexane, 97%   

  • 1069120-19-9

  • 1g

  • 6653.0CNY

  • Detail

1069120-19-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl cis-4-(2-hydroxyethyl)-cyclohexylcarbamate

1.2 Other means of identification

Product number -
Other names tert-butyl ((1s,4s)-4-(2-hydroxyethyl)cyclohexyl)carbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1069120-19-9 SDS

1069120-19-9Relevant articles and documents

Optimization of antitumor modulators of pre-mRNA splicing

Lagisetti, Chandraiah,Palacios, Gustavo,Goronga, Tinopiwa,Freeman, Burgess,Caufield, William,Webb, Thomas R.

supporting information, p. 10033 - 10044 (2014/01/17)

The spliceosome regulates pre-mRNA splicing, which is a critical process in normal mammalian cells. Recently, recurrent mutations in numerous spliceosomal proteins have been associated with a number of cancers. Previously, natural product antitumor agents have been shown to interact with one of the proteins that is subject to recurrent mutations (SF3B1). We report the optimization of a class of tumor-selective spliceosome modulators that demonstrate significant in vivo antitumor activity. This optimization culminated in the discovery of sudemycin D6, which shows potent cytotoxic activity in the melanoma line SK-MEL-2 (IC50 = 39 nM) and other tumor cell lines, including JeKo-1 (IC50 = 22 nM), HeLa (IC50 = 50 nM), and SK-N-AS (IC 50 = 81 nM). We also report improved processes for the synthesis of these compounds. Our work supports the idea that sudemycin D6 is worthy of further investigation as a novel preclinical anticancer agent with application in the treatment of numerous human cancers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1069120-19-9